Related Experiment Video
Updated: Dec 20, 2025

Description of a Swine Infant Model of Volume-Controlled Hemorrhagic Shock
Published on: November 3, 2023
Effect of high-volume hemofiltration on children with sepsis
Botao Ning1, Sheng Ye2, Yi Lyu3
1Pediatric Intensive Care Unit, Shanghai Children's Medical Center Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai 200127, China.
Insights
High-volume hemofiltration (HVHF) improved sepsis outcomes in children. This treatment enhanced oxygenation, reduced inflammatory markers, and lowered mortality risk compared to standard continuous renal replacement therapy (CRRT).
Area of Science:
- Pediatric Intensive Care
- Nephrology
- Critical Care Medicine
Background:
- Sepsis presents a significant challenge in pediatric intensive care units (PICUs), often leading to poor prognoses.
- Continuous renal replacement therapy (CRRT) is a standard treatment, but its efficacy in pediatric sepsis requires further evaluation.
- High-volume hemofiltration (HVHF) is an alternative modality for fluid management and toxin removal.
Purpose of the Study:
- To compare the effectiveness of routine CRRT versus HVHF in pediatric patients diagnosed with sepsis.
- To evaluate the impact of HVHF on key clinical and biochemical markers of sepsis severity and organ function.
- To assess the influence of HVHF on mortality rates in pediatric sepsis patients.
Main Methods:
- A prospective, randomized, controlled, open-label trial involving 47 children with sepsis.
- Patients were assigned to either routine CRRT (22 patients) or HVHF (25 patients) within 6 hours of sepsis diagnosis.
- Key parameters monitored included oxygenation index, serum creatinine, urea, lactate, inflammatory cytokines (IL-6, IL-10, TNF-α), PRISM III score, and 28-day mortality.
Main Results:
- HVHF significantly improved the oxygenation index and arterial lactate levels at 48 and 72 hours post-treatment compared to CRRT.
- Serum creatinine, urea, IL-6, IL-10, TNF-α, and PRISM III scores were significantly ameliorated in the HVHF group after 72 hours.
- While HVHF showed marked improvements in sepsis markers, there was no statistically significant difference in 28-day mortality between the HVHF and CRRT groups.
Conclusions:
- High-volume hemofiltration (HVHF) demonstrates potential as an effective treatment strategy for pediatric sepsis.
- HVHF offers significant benefits in improving organ function and reducing inflammatory responses in children with sepsis.
- Further research is warranted to explore the impact of HVHF on long-term outcomes and mortality in pediatric sepsis.
Background:
Sepsis has always been a challenge in pediatric intensive care unit (PICU) with poor prognosis. In order to evaluate the effect between routine continuous renal replacement therapy (CRRT) and high-volume hemofiltration (HVHF) in children with sepsis, we performed out this prospective, randomized, controlled, open-label trial.
Methods:
Forty-seven children with sepsis were enrolled from January 2015 to December 2016. Twenty-two patients in Control group received routine CRRT and 25 patients in HVHF group received HVHF within 6 hours after the diagnosis of sepsis. The oxygenation index, serum creatinine, urea, lactate, inflammatory cytokines (IL-6, IL-10, and TNF-α), pediatric risk of mortality III (PRISM III) and 28-day mortality rate were collected and compared.
Results:
The oxygenation index in HVHF group and Control group was significantly increased at 48 hours (P<0.01) and 72 hours after treatment (P<0.05). The same result of arterial lactate was observed. Serum creatinine, urea, IL-6, IL-10, TNF-α and PRISM III score were significantly ameliorated after 72 hours treatment in HVHF group (P<0.01), while there was no significant difference in Control group. After 72 hours of treatment, the oxygenation index, lactate, serum creatinine, urea, TNF-α, IL-6, IL-10 and PRISM III score in HVHF group were significantly improved compared with Control group (P<0.01). There is no significant difference on 28-day mortality between the two groups (P>0.05).
Conclusions:
HVHF might be an effective treatment for children with sepsis.
Related Concept Videos
Extracorporeal Removal of Drugs: Hemoperfusion and Hemofiltration
Extracorporeal Removal of Drugs: Continuous Renal Replacement Therapy
Hemodialysis II: Procedure and Complications
Pharmacokinetics in Pediatric Patients: Drug Excretion
Pharmacokinetics in Pediatric Patients: Drug Distribution
Continuous Renal Replacement Therapy

